Search Login Register
carbonyl reductase (NADPH)
Summary
40
relevant articles (0 outcomes,
2 trials/studies)
found for this Bio-Agent
Description:
acts on a wide variety of carbonyl compounds including quinones, aldehydes, ketoaldehydes, daunorubicin, prostaglandins E and F; converts 13,14-dihydro-15keto-PGF2alpha to 13,14-dihydroPGF2alpha
Also Known As:
13,14-dihydroprostaglandin F2alpha synthetase; AKR1C19 protein, mouse; AKR7A5 protein, mouse; NADPH-carbonyl reductase; NADPH-dependent carbonyl reductase Show All >>
Key Diseases for which carbonyl reductase (NADPH) is
Relevant
-
Hepatocellular Carcinoma (Hepatoma)
:
2 studies in 7 results
-
Neoplasms (Cancer)
:
1 study in 10 results
-
Non-Small-Cell Lung Carcinoma (Carcinoma, Non-Small Cell Lung)
:
1 study in 4 results
-
Breast Neoplasms (Breast Cancer)
:
4 results
-
Diabetes Complications
:
3 results
Show All >>
Drugs Related to carbonyl reductase (NADPH)
-
Enzymes
-
Messenger RNA (mRNA)
-
NAD (NADH)
-
glutathione S-transferase M1
-
benzoquinone (quinone)
-
Oxidoreductases
-
Aldehyde Reductase (Aldose Reductase)
-
Testosterone 5-alpha-Reductase (Testosterone 5 alpha Reductase)
-
Proteins (Proteins, Gene)
-
Phosphopyruvate Hydratase (Enolase)
Show All >>
Therapies Related to carbonyl reductase (NADPH)
CureHunter Inc. provides medical information and specifically does NOT provide medical advice.
© Copyright 2003-2008 CureHunter Inc., MeSH copyright NLM, Journal Articles copyright original owners.